Biochemistry, Genetics and Molecular Biology
Myofibroblast
100%
SOX9
64%
Mouse
49%
Skeletal Muscle
38%
PAK1
32%
Mechanotransduction
32%
Fibroblast
32%
Circadian Rhythm
32%
Selective Autophagy
32%
Autophagy
32%
Upregulation
32%
Secretion (Process)
32%
Hepatic Stellate Cell
19%
Zebra Fish
19%
Mechanical Stress
17%
Scar Formation
16%
Transcription
14%
Transcription Factors
13%
Filamin
12%
C2C12
12%
CLOCK
12%
BAG3
12%
Wild Type
12%
Mouse Model
11%
Tension
11%
YAP1
10%
Fibrogenesis
10%
Protein Unfolding
9%
Bleomycin
8%
Derepression
8%
Genetic Manipulation
8%
Myosin ATPase
8%
Heterochromatin
8%
Gene Control
8%
Co-Chaperone
6%
Mutagenesis
6%
CRISPR/Cas9
6%
Loss of Function Mutation
6%
Microarrays
6%
Peptidase
6%
Mediator
6%
ATAC-Seq
6%
AOC3
6%
Muscle Function
6%
Western Blot
5%
Proteomics
5%
Cell Migration
5%
Transdifferentiation
5%
Genome Wide Association Study
5%
Pericyte
5%
Medicine and Dentistry
Nonalcoholic Fatty Liver
64%
Myofibroblast
64%
Liver Disease
49%
Liver Fibrosis
38%
Kidney Fibrosis
32%
Selective Autophagy
32%
Myopathy
32%
Upregulation
32%
Circadian Rhythm
32%
Cystic Fibrosis
32%
Fibrosis
22%
Hepatic Stellate Cell
19%
Risk Stratification
13%
Genetic Variability
13%
Biological Marker
13%
Extracellular Matrix
12%
Kidney Injury
12%
Fibrogenesis
12%
C2C12
12%
Filamin
12%
Chronic Disease
12%
Transcription Factors
12%
BAG3
12%
Diagnosis
9%
Protein Unfolding
9%
Patient with Cystic Fibrosis
6%
Skeletal Muscle
6%
In Vitro
6%
Injury
6%
Digitalis
6%
Experimental Renal Fibrosis
6%
Chronic Kidney Disease
6%
Mutagenesis
6%
Pericyte
6%
Chaperone
6%
Muscle Function
6%
Rho Guanine Nucleotide Dissociation Inhibitor
6%
Cell Transdifferentiation
6%
Cas9
6%
Peptidase
6%
Clustered Regularly Interspaced Short Palindromic Repeat
6%
Metabolic Syndrome
6%
Mediator
6%
Actin Polymerization
6%
Loss of Function Mutation
6%
Kyphoscoliosis
6%
Myoblast
6%
Disease Severity
6%
Disease Exacerbation
6%
Carcinoma
6%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Disease
53%
Liver Fibrosis
43%
Mouse
32%
Cystic Fibrosis
32%
Muscle Hypertrophy
32%
Mouse Model
32%
Disease
32%
Muscle Disease
32%
Therapeutic Window
32%
Symptom
32%
Genetic Disorder
32%
Nonalcoholic Fatty Liver
32%
Muscle Atrophy
32%
Fibrosis
29%
Chronic Disease
21%
Biological Marker
16%
Metabolic Syndrome X
10%
Inflammation
10%
Carcinoma
10%
Disease Exacerbation
10%
Injury
10%
Rho Guanine Nucleotide Dissociation Inhibitor
10%
Disease Severity
10%
Experimental Renal Fibrosis
6%
